BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33836095)

  • 1. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival.
    Olecki EJ; Stahl KA; Torres MB; Peng JS; Shen C; Dixon MEB; Gusani NJ
    J Surg Oncol; 2021 Jul; 124(1):79-87. PubMed ID: 33836095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.
    Swords DS; Zhang C; Presson AP; Firpo MA; Mulvihill SJ; Scaife CL
    Surgery; 2018 Apr; 163(4):753-760. PubMed ID: 29248179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.
    Hamidian Jahromi A; Zibari GB; Jafarimehr E; Chu Q; Wellman GP; Shi R; Johnson LW; Shokouh-Amiri H
    Int Surg; 2014; 99(1):62-70. PubMed ID: 24444272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.
    Ariake K; Motoi F; Ohtsuka H; Fukase K; Masuda K; Mizuma M; Hayashi H; Nakagawa K; Morikawa T; Maeda S; Takadate T; Naitoh T; Egawa S; Unno M
    Surg Today; 2017 Dec; 47(12):1434-1442. PubMed ID: 28434080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
    Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology.
    Olecki EJ; Stahl K; Peng JS; Dixon M; Gusani NJ; Shen C
    Ann Surg Oncol; 2021 Mar; 28(3):1581-1592. PubMed ID: 32851518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma.
    Salami A; Alvarez NH; Joshi ART
    HPB (Oxford); 2017 Nov; 19(11):1008-1015. PubMed ID: 28838634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.
    Passeri MJ; Baker EH; Siddiqui IA; Templin MA; Martinie JB; Vrochides D; Iannitti DA
    Curr Oncol; 2019 Jun; 26(3):e346-e356. PubMed ID: 31285679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
    Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.